Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
A mild headache that resolves in an hour might not appear in trial data but could still concern someone using the peptide at home
"Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design
Its formulation ensures peptide stability, high purity, and reproducible activity under recommended storage conditions
Phase 2 trial results by dose (48 weeks) Phase 3 TRIUMPH-4 results (68 weeks) The phase 3 TRIUMPH-4 data, released in early 2026, confirmed and exceeded the phase 2 results
Mol Biol Evol 18:691699 World Health O (2024) Global tuberculosis report 2024
Clinicians should also avoid or adjust therapy in individuals with active peptic ulcer disease due to theoretical choline-mediated increases in gastric volume and in those receiving levodopa, as pantothenic-acid derivatives may interfere with levodopa absorption
US$ 26.93
US$ 24.79
US$ 28.87
US$ 20.41
/assets/images/provider/photos/2814339.jpeg)
